{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["5f58e9e9-e6e4-4e0c-9fde-6a1d748efbcf", "Q1", 400658980, "BLUESTONE STRATEGIES, LLC", 193923, "PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)", 2015, "first_quarter", "2015-04-18T09:59:38.850000-04:00", 50000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/5f58e9e9-e6e4-4e0c-9fde-6a1d748efbcf/\", \"filing_uuid\": \"5f58e9e9-e6e4-4e0c-9fde-6a1d748efbcf\", \"filing_type\": \"Q1\", \"filing_type_display\": \"1st Quarter - Report\", \"filing_year\": 2015, \"filing_period\": \"first_quarter\", \"filing_period_display\": \"1st Quarter (Jan 1 - Mar 31)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/5f58e9e9-e6e4-4e0c-9fde-6a1d748efbcf/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"50000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Chris Long\", \"dt_posted\": \"2015-04-18T09:59:38.850000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"P.O. Box 76811\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"Washington\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20013\", \"registrant\": {\"id\": 400658980, \"url\": \"https://lda.senate.gov/api/v1/registrants/400658980/\", \"house_registrant_id\": null, \"name\": \"BLUESTONE STRATEGIES, LLC\", \"description\": \"Government Relations\", \"address_1\": \"PO Box 76811\", \"address_2\": null, \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20013\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"BEHRENDS FOSTER\", \"contact_telephone\": \"+1 202-603-4902\", \"dt_updated\": \"2026-01-31T11:04:14.219200-05:00\"}, \"client\": {\"id\": 193923, \"url\": \"https://lda.senate.gov/api/v1/clients/193923/\", \"client_id\": 48, \"name\": \"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)\", \"general_description\": \"National Trade Association\", \"client_government_entity\": false, \"client_self_select\": false, \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"DC\", \"ppb_state_display\": \"District of Columbia\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2011-01-14\"}, \"lobbying_activities\": [{\"general_issue_code\": \"MMM\", \"general_issue_code_display\": \"Medicare/Medicaid\", \"description\": \"Medicare; Medicaid; Pharmacy Payments; Average Manufacturer Pricing; Prescription Drug Reimburesement; Direct Negotiation; Medicare Drug Rebate; Medicare Part D Coverage; and HR 804, Expanding the Availability of Medicare Data Act\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 52786, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"BEHRENDS\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"FOSTER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Chief of Staff, Representative Dave Camp\", \"new\": false}, {\"lobbyist\": {\"id\": 52956, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"CHRISTOPHER\", \"nickname\": null, \"middle_name\": \"M\", \"last_name\": \"LONG\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Legislative Assistant, Representative George (Buddy) Darden\", \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"PHA\", \"general_issue_code_display\": \"Pharmacy\", \"description\": \"Pharmacy Act; Generic Brand Settlement; Generic Dispensing; Generic Biologics; Specialty Drug Issues and 21st Century Cures legislation.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 52786, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"BEHRENDS\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"FOSTER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Chief of Staff, Representative Dave Camp\", \"new\": false}, {\"lobbyist\": {\"id\": 52956, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"CHRISTOPHER\", \"nickname\": null, \"middle_name\": \"M\", \"last_name\": \"LONG\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Legislative Assistant, Representative George (Buddy) Darden\", \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"Implementation of the Patient and Affordable Care Act (P.L. 11-148); Legislation Amending P.L. 111-148; H.R. 244, MAC Transparency Act; HR 793, Ensuring Access to Local Pharmacies Act; Electronic Pricing; Chronic Care; PBM Disclosure; Formulary Requirements; Generic Drug Co-Payments; Essential Health Benefits; Medical Loss Ratio and Preferred Pharmacy Networks.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 52786, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"BEHRENDS\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"FOSTER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Chief of Staff, Representative Dave Camp\", \"new\": false}, {\"lobbyist\": {\"id\": 52956, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"CHRISTOPHER\", \"nickname\": null, \"middle_name\": \"M\", \"last_name\": \"LONG\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Legislative Assistant, Representative George (Buddy) Darden\", \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["5f58e9e9-e6e4-4e0c-9fde-6a1d748efbcf"], "units": {}, "query_ms": 80.08987305220217, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}